Recent PLUR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:00:06 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/18/2024 08:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:30:34 AM
- Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates • GlobeNewswire Inc. • 07/18/2024 06:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:30:21 AM
- Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply • GlobeNewswire Inc. • 07/08/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 11:00:32 AM
- Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges • GlobeNewswire Inc. • 06/18/2024 10:30:00 AM
- U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract • GlobeNewswire Inc. • 06/06/2024 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:05:18 PM
- Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale • GlobeNewswire Inc. • 05/20/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/09/2024 08:13:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/09/2024 08:10:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:00:37 PM
- Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method • GlobeNewswire Inc. • 04/08/2024 11:00:00 AM
- Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences • GlobeNewswire Inc. • 03/28/2024 11:15:00 AM
- Pluri Inc. Announces 1-for-8 Reverse Share Split • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report • GlobeNewswire Inc. • 03/21/2024 11:00:00 AM
- Engage with Pluri's Talent: Exciting Conference Appearances Ahead • GlobeNewswire Inc. • 03/19/2024 08:00:00 AM
- Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing • GlobeNewswire Inc. • 03/14/2024 11:00:00 AM
- Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals • GlobeNewswire Inc. • 02/28/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM